Unknown NA INTERVENTIONAL 2-arm NCT05037552

Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve (FLOKIP)

Additional Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve During Laparoscopic Ovarian Cystectomy

Sponsor: Baxter Healthcare Corporation

Conditions Benign Ovarian Cyst Cystectomy

Interventions Bipolar coagulation Coagulation by FLOSEAL haemostatic agent

Updated 8 times since 2021 Last updated: Mar 10, 2023 Started: Sep 30, 2023 Primary completion: Jan 30, 2025 Completion: Sep 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Benign Ovarian Cyst and Cystectomy and is currently ongoing. Baxter Healthcare Corporation leads this study, which shows 8 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Nov 2025 — Present [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Sep 2024 — Nov 2025 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Apr 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA
Mar 2022 — Apr 2023 [monthly]

Not Yet Recruiting NA

▶ Show 3 earlier versions

Jan 2022 — Mar 2022 [monthly]

Not Yet Recruiting NA
Dec 2021 — Jan 2022 [monthly]

Not Yet Recruiting NA
Oct 2021 — Dec 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxter Healthcare Corporation
University Hospital, Montpellier

Data source: University Hospital, Montpellier

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montpellier, France
• Nîmes, France